Biotech Values

[pfrien]

I bought today as well. I can tell you that it was not easy picking up shares. The ask kept moving away. With an $18 IPO last year, i suppose the sellers have done their worst already. What is appealing is that the company has consistently given quarterly guidance that matches consensus expectations. The consensus revenue targets for next year look low. $110MM is about 30,000 tests right? I thought maybe 35,000 or even 40,000 tests.